10 employees
Lymphact is a biopharmaceutical start-up focused on developing innovative personalized medical treatments.
2013
$358K
from 2 investors over 2 rounds
Lymphact raised undisclosed on January 1, 2014
Investors: Bynd Venture Capital
Lymphact raised $358K on May 31, 2013
Investors: Portugal Ventures